GENERAL STRUCTURE OF ANSN-BASED FLUOROGENIC SUBSTRATES
The general structure of 6-amino-1-naphthalenesulfonamide-based (ANSN) fluorogenic substrates is illustrated. In the present family of compounds, R1 is a tripeptide of which the COOH-terminal residue is typically an arginine. R2 and R3 may be either a hydrogen, alkyl, aryl, or cycloalkyl group. The dotted line indicates the site of hydrolysis by the various serine proteases.
Substrates containing the fluorescent reporter group 6-amino-1-naphthalene-sulfonamide (ANSN) are useful compounds for monitoring the enzyme activity of various serine proteases (1-12). In this class of compounds, the ANSN reporter group is linked (in the R1 position) to short tri-peptide sequences. The peptide sequences are designed to optimize the interaction between the enzyme and substrate. Additional components which may be added to the R2 and R3 positions reflect changes in the P' subsite positions, and generally affect the kinetic parameters of the substrates. Compounds which are effective substrates are hydrolyzed between the tri-peptide and the ANSN group. Once cleaved from the peptide moiety, the ANSN group exhibits about a 1000 fold increase in relative fluorescence.
The kinetic properties identified on the following page will aid in the selection of an appropriate substrate. The ANSN substrates have proved especially useful for the analyses of factor VIIa (1-5,7,9,10,12). Although the substrate hydrolysis rates are relatively slow for factor VIIa alone, several compounds such as compound SN-17a exhibit a large change in kcat when tissue factor is incorporated into the assay system.
USAGE
INFORMATION:
ANSN-based
substrates are provided as 10mM stock solutions in
DMSO, and are
generally useful for analyzing enzymes within a concentration
range of 400 nM to as low as 50pM. ANSN substrates are
typically used at final concentrations of 50 to 100 µM and may be
diluted to this final concentration in most physiologic buffers (ie.,
TBS, HBS, PBS, etc). Reactions (the relative change in fluorescence)
may
be monitored using standard fluorometers or fluorescent plate
readers. Kinetic or endpoint modes may be used with the
instrument set at the following wavelengths (excitation=352nm,
emission=470nm). Light artifacts can be minimized by employing a 390 to 450 nm long-pass cutoff filter in the emission beam.
Kinetic properties of each substrate are listed in the table below,
and a list of journal references is included below the table for
examples of use.
The stock substrate solutions in DMSO should be stored frozen at 4°C or colder, and should be protected from light. Under these conditions the compounds will remain stable for over one year.
|
| |
ANSN - BASED - FLUOROGENIC SUBSTRATES |
| CAT.# |
STRUCTURE |
KINETIC PROPERTIES
(KM - µM; kcat - s-1; kcat/KM - M-1s-1x10-5) |
PRICING |
IIa |
VIIa |
VIIa/TF |
Xa |
XIa |
aPC |
tPA |
Plasmin |
| SN-5 |
D-AFK-ANSNH-iC4H9.2HBr
F.W. = 786.6
(useful for plasmin) |
KM
kcat
kcat/KM |
ND
ND
ND |
ND
ND
ND |
ND
ND
ND |
ND
ND
ND |
ND
ND
ND |
ND
ND
ND |
ND
ND
ND |
130
3.7
0.28 |
| SN-7 |
Mes-D-LGR-ANSN(C2H5)2
F.W. = 682.8
(useful for factor Xa) |
KM
kcat
kcat/KM |
31
0.63
0.2 |
180
0.007
0.0004 |
200
0.79
0.04 |
125
36
2.9 |
580
15
0.26 |
113
0.055
0.005 |
ND
ND
ND |
ND
ND
ND |
| SN-13a |
D-LPR-ANSNH-C3H7 • 2 HCl
F.W. = 721.74
(useful for factor XIa) |
KM
kcat
kcat/KM |
0.5
19
380 |
300
0.07
0.002 |
300
4.5
0.15 |
171
3.3
0.19 |
75
53
7.1 |
45
52
12 |
98
0.31
0.03 |
ND
ND
ND |
| SN-17a |
D-FPR-ANSNH-C6H11 • 2 HCl
F.W. = 777.81
(useful for IIa & factor VIIa) |
KM
kcat
kcat/KM |
0.4
17
430 |
150
0.05
0.004 |
330
8.4
0.25 |
150
0.32
0.02 |
ND
ND
ND |
7.8
6.6
8.6 |
36
0.074
0.02 |
ND
ND
ND |
| SN-17c |
D-FPR-ANSNH-C4H9 • 2 HCl
F.W. = 751.76
(useful for factor VIIa) |
KM
kcat
kcat/KM |
ND
ND
ND |
186
0.11
0.006 |
102
2.7
0.26 |
ND
ND
ND |
ND
ND
ND |
53
21
4.0 |
ND
ND
ND |
ND
ND
ND |
| SN-18 |
Boc-L-(p-F)FPR-ANSNH-C2H5
F.W. = 768.92
(useful for tPA) |
KM
kcat
kcat/KM |
3.7
44
120 |
50
0.008
0.002 |
217
0.88
0.04 |
ND
ND
ND |
ND
ND
ND |
ND
ND
ND |
71
1.03
0.15 |
ND
ND
ND |
| SN-20 |
Boc-L-FPR-ANSNH-C2H5
F.W. = 750.90
(useful for thrombin) |
KM
kcat
kcat/KM |
17.0
58
34 |
ND
ND
ND |
ND
ND
ND |
100
0.31
0.003 |
ND
ND
ND |
540
2.2
0.04 |
47
0.011
0.002 |
ND
ND
ND |
| SN-45 |
L-EGR-ANSNH-C3H7 • 2 HBr
F.W. = 724.6
(useful for factor XIa) |
KM
kcat
kcat/KM |
100
2.5
0.25 |
ND
ND
ND |
ND
ND
ND |
110
0.20
0.02 |
225
82
3.6 |
440
17
0.39 |
ND
ND
ND |
ND
ND
ND |
| SN-54 |
BOC-D-VLR-ANSNH-C4H9
F.W. = 746.98
(useful for aPC) |
KM
kcat
kcat/KM |
19
0.055
0.03 |
42
0.007
0.002 |
170
1.6
0.09 |
19
0.055
0.03 |
ND
ND
ND |
3.9
2.1
5.2 |
ND
ND
ND |
ND
ND
ND |
| SN-59 |
D-VPR-ANSNH-C4H9 • 2 HCl
F.W. = 703.73
(useful for thrombin and aPC) |
KM
kcat
kcat/KM |
2.0
110
550 |
89
0.019
0.002 |
52
0.76
0.14 |
160
3.3
0.21 |
520
92
1.8 |
54
72
13 |
110
0.71
0.065 |
ND
ND
ND |
|
ND = NOT DETERMINED
Sample
publications referencing our Substrates:
-
Komissarov,
A., et al., Am J Physiol
Lung Cell Mol Physiol (August 7, 2009). (SN-5)
-
Butenas
et al. Thromb
Haemost 1997;78:1193-201.
This
publication list is not all encompassing, and is only meant to
provide limited examples of how Haematologic Technologies'
products are used. We encourage you to search the literature
for other examples pertinent to your experimentation, and to
contact us with any technical questions.
PRICING
INQUIRE
ABOUT THESE PRODUCTS
|
|
|
References
1. Butenas, S., et al., Biochemistry, 31, 5399 (1992).
2. Lawson, J.H., et al., J. Biol. Chem., 267, 4834 (1992).
3. Lawson, J.H., et al., Methods in Enzymology, 222, 177 (1993).
4. Butenas, S., et al., Biochemistry, 32, 6531 (1993).
5. Butenas, S., et al., J. Biol. Chem., 269, 25838 (1994).
6. Butenas, S., et al., Anal. Biochem., 225, 231 (1995).
7. Butenas, S., and Mann, K.G., Biochemistry, 35, 1904 (1996).
8. Butenas, S., et al., Biochemistry, 36, 2123 (1997).
9. Butenas, S., et al., J. Biol. Chem., 272, 21527 (1997).
10. Butenas, S., et al., Thromb. Haemost., 78, 1193 (1997).
11. Hockin,M.F.,et al.,Arterioscler.Thromb.Vasc.Biol.,in press(1997).
12. Butenas, S., et al., U.S.A. patent # 5,399,487. |
|
|